O=C(c1ccccc1)C1N=NN(Cc2ccccc2[N+](=O)[O-])C1C(=O)c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?